Ivermectin Studies. Foster MD2 Hideaki Hanaki PhD1 and Satoshi Ōmura PhD1 1 Kitasato University Ōmura Satoshi Memorial Institute 2 Keio University Faculty of Pharmacy. And anecdotally for a subset of long haulers.
This is a randomized controlled trial to evaluate the efficacy of ivermectin in COVID-19 outpatients reducing the risk of progression to severe disease. View the data and studies here. Ivermectin is an FDA-approved broad spectrum anti-parasitic agent Gonzalez Canga et al 2008 that in recent years we along with other groups have shown to have anti-viral activity against a broad range of viruses Gotz et al 2016.
As the level of evidence of these data is low the efficacy of ivermectin against COVID-19.
Real-time meta analysis of 56 studies. Originally used as anti-parasitic worms river blindness now recognized as broad anti-viral anti-bacterial. Also watch Congressional testimony from Dr. And anecdotally for a subset of long haulers.